Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.
- A. Kudelka, D. Tresukosol, +11 authors J. Kavanagh
- Medicine
- Journal of clinical oncology : official journal…
- 1 May 1996
PURPOSE
To determine the efficacy and toxicity of topotecan administered as a 5-day intravenous infusion in patients with advanced ovarian cancer refractory to cisplatin-based chemotherapy.
… Expand
Extramammary Paget's disease of the perineal skin: role of radiotherapy.
- P. Besa, T. Rich, L. Delclós, C. Edwards, D. Ota, J. Wharton
- Medicine
- International journal of radiation oncology…
- 1992
We have reviewed our treatment results in 65 patients with extramammary Paget's disease arising in the vulva, perianal area, or scrotum. In 30 patients with primary disease, positive surgical margins… Expand
Didelphic uterus and obstructed hemivagina with renal agenesis: case report and review of the literature.
- R. Zurawin, J. Dietrich, M. Heard, C. Edwards
- Medicine
- Journal of pediatric and adolescent gynecology
- 1 April 2004
Congenital disorders of development are more common than previously reported and the correct diagnosis is frequently missed leading to suboptimal treatment. Eight cases of uterus didelphys with… Expand
Secondary cytoreductive surgery for recurrent epithelial ovarian cancer.
- M. Morris, D. Gershenson, J. Wharton, L. Copeland, C. Edwards, C. A. Stringer
- Medicine
- Gynecologic oncology
- 1989
Thirty patients with recurrent epithelial ovarian carcinoma who underwent secondary tumor-reductive surgery at M. D. Anderson Cancer Center were studied retrospectively. All had been initially… Expand
Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice.
- B. L. Black, J. Croom, E. J. Eisen, A. Petro, C. Edwards, R. Surwit
- Biology, Medicine
- Metabolism: clinical and experimental
- 1 November 1998
The C57BL/6 (B6) mouse is more sensitive to the effects of a high-fat diet than the A/J strain. The B6 mouse develops severe obesity, hyperglycemia, and hyperinsulinemia when fed this dietary… Expand
A dynamic test of lower extremity function following anterior cruciate ligament reconstruction and rehabilitation.
- P. M. Juris, E. Phillips, C. Dalpe, C. Edwards, R. Gotlin, D. Kane
- Medicine
- The Journal of orthopaedic and sports physical…
- 1 October 1997
It is essential to assess the functional status of patients with surgically reconstructed and rehabilitated anterior cruciate ligaments prior to discharge. This study established a testing paradigm… Expand
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
- C. Verschraegen, T. Levy, +10 authors J. Kavanagh
- Medicine
- Journal of clinical oncology : official journal…
- 1 February 1997
PURPOSE
A phase II study was performed to evaluate the antitumor activity and toxicity of irinotecan (CPT-11), a water-soluble derivative of camptothecin, in patients with prior chemotherapy-treated… Expand
Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer
- S. Vadhan-Raj, C. Verschraegen, +8 authors J. Kavanagh
- Medicine
- Annals of Internal Medicine
- 7 March 2000
Myelosuppression is a serious complication in patients who are receiving chemotherapy for cancer. The use of myeloid growth factors has reduced the incidence of febrile neutropenia (1, 2). However,… Expand
Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas
- L. Jones, C. Edwards, R. Freedman, M. T. Tan, H. S. Gallager
- Biology, Medicine
- International journal of cancer
- 15 November 1983
Only 69% (42 of 61) of the documentated ovarian tumor specimens received between September 1981 and August 1982 contained 75% or more viable tumor. Of the 42 measured for estrogen receptors (ER) and… Expand
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or…
- R. Freedman, A. Kudelka, +11 authors C. Platsoucas
- Medicine
- Clinical cancer research : an official journal of…
- 1 June 2000
To identify strategies that enhance tumor-specific immunity in patients with ovarian carcinoma, 22 patients received four to six doses of i.p. recombinant IFN-gamma (rIFN-gamma), 200 microg/m2 on… Expand